FDA Inspection
CorneaGen LLCCorneaGen LLC – FDA Inspection, Sep 24, 2021
Record Details
This FDA Inspection record concerns CorneaGen LLC, with an inspection on September 24, 2021, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- CorneaGen LLC
- Inspection Date
- September 24, 2021
- Product Type
- Biologics
View Company Profile
ID · d1a660ae-7f2b-42ab-a32e-be6a9997c7f8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1152947
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of CorneaGen LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 30, 2026 | Not classified | Seattle District Office | |
| January 13, 2023 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for CorneaGen LLC
- FDA Inspection 1320762 - 2026-04-30
- FDA Inspection 1195552 - 2023-01-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.